ONCOMAX ACQUISITION CORP has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ULTRAHUMAN FOUR LTD, ULTRAHUMAN EIGHT LTD and JIE HAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ma Jing | 11 |
#2 | Guo Yajun | 7 |
#3 | Guo Yanjun | 4 |
Publication | Filing date | Title |
---|---|---|
IL172243D0 | Preparation and application of anti-tumor bifunctional fusion proteins | |
US2005232926A1 | Antibodies specific for cancer associated antigen SM5-1 and uses thereof | |
US2005232931A1 | Preparation and application of anti-tumor bifunctional fusion proteins | |
EP1633398A2 | Preparation and application of anti-tumor bifunctional fusion proteins | |
CA2528182A1 | Antibodies specific for cancer associated antigen sm5-1 and uses thereof |